|
2023 Journal Article Prospective inter-and intra-tracer repeatability analysis of radiomics features in [68Ga]Ga-PSMA-11 and [18F]F-PSMA-1007 PET scans in metastatic prostate cancerKendrick, Jake, Francis, Roslyn J., Hassan, Ghulam Mubashar, Rowshanfarzad, Pejman, Ong, Jeremy S.L., Jeraj, Robert, Barry, Nathaniel, Hagan, Tammy and Ebert, Martin A. (2023). Prospective inter-and intra-tracer repeatability analysis of radiomics features in [68Ga]Ga-PSMA-11 and [18F]F-PSMA-1007 PET scans in metastatic prostate cancer. British Journal of Radiology, 96 (1152) 20221178, 1-11. doi: 10.1259/bjr.20221178 |
|
2023 Journal Article Prognostic utility of RECIP 1.0 with manual and AI-based segmentations in biochemically recurrent prostate cancer from [68Ga]Ga-PSMA-11 PET imagesKendrick, Jake, Francis, Roslyn J., Hassan, Ghulam Mubashar, Rowshanfarzad, Pejman, Ong, Jeremy S. L., McCarthy, Michael, Alexander, Sweeka and Ebert, Martin A. (2023). Prognostic utility of RECIP 1.0 with manual and AI-based segmentations in biochemically recurrent prostate cancer from [68Ga]Ga-PSMA-11 PET images. European Journal of Nuclear Medicine and Molecular Imaging, 50 (13), 4077-4086. doi: 10.1007/s00259-023-06382-2 |
|
2023 Journal Article Improved arterial inflammation with high dose omega-3 fatty acids in patients with elevated lipoprotein(a): selective effect of eicosapentaenoic acid?Ward, Natalie C., Ying, Qidi, Chan, Dick C., Pang, Jing, Mori, Trevor A., Schultz, Carl J., Dwivedi, Girish, Francis, Roslyn J. and Watts, Gerald F. (2023). Improved arterial inflammation with high dose omega-3 fatty acids in patients with elevated lipoprotein(a): selective effect of eicosapentaenoic acid?. Journal of Clinical Lipidology, 17 (5), 694-699. doi: 10.1016/j.jacl.2023.08.004 |
|
2023 Journal Article Delineation and agreement of FET PET biological volumes in glioblastoma: results of the nuclear medicine credentialing program from the prospective, multi-centre trial evaluating FET PET In Glioblastoma (FIG) study—TROG 18.06Barry, Nathaniel, Francis, Roslyn J., Ebert, Martin A., Koh, Eng-Siew, Rowshanfarzad, Pejman, Hassan, Ghulam Mubashar, Kendrick, Jake, Gan, Hui K., Lee, Sze T., Lau, Eddie, Moffat, Bradford A., Fitt, Greg, Moore, Alisha, Thomas, Paul, Pattison, David A., Akhurst, Tim, Alipour, Ramin, Thomas, Elizabeth L., Hsiao, Edward, Schembri, Geoffrey P., Lin, Peter, Ly, Tam, Yap, June, Kirkwood, Ian, Vallat, Wilson, Khan, Shahroz, Krishna, Dayanethee, Ngai, Stanley, Yu, Chris ... Scott, Andrew M. (2023). Delineation and agreement of FET PET biological volumes in glioblastoma: results of the nuclear medicine credentialing program from the prospective, multi-centre trial evaluating FET PET In Glioblastoma (FIG) study—TROG 18.06. European Journal of Nuclear Medicine and Molecular Imaging, 50 (13), 3970-3981. doi: 10.1007/s00259-023-06371-5 |
|
2023 Journal Article [18F]-fluoroethyl-L-tyrosine (FET) in glioblastoma (FIG) TROG 18.06 study: protocol for a prospective, multicentre PET/CT trialKoh, Eng-Siew, Gan, Hui K., Senko, Clare, Francis, Roslyn J., Ebert, Martin, Lee, Sze Ting, Lau, Eddie, Khasraw, Mustafa, Nowak, Anna K., Bailey, Dale L., Moffat, Bradford A., Fitt, Greg, Hicks, Rodney J., Coffey, Robert, Verhaak, Roel, Walsh, Kyle M., Barnes, Elizabeth H., De Abreu Lourenco, Richard, Rosenthal, Mark, Adda, Lucas, Foroudi, Farshad, Lasocki, Arian, Moore, Alisha, Thomas, Paul A., Roach, Paul, Back, Michael, Leonard, Robyn and Scott, Andrew M. (2023). [18F]-fluoroethyl-L-tyrosine (FET) in glioblastoma (FIG) TROG 18.06 study: protocol for a prospective, multicentre PET/CT trial. BMJ Open, 13 (8) e071327. doi: 10.1136/bmjopen-2022-071327 |
|
2023 Journal Article Targeted alveo-pleural fistula endobronchial valve treatment using ventilation scintigraphySidhu, Calvin, Ratnagobal, Shoba, Thomas, Rajesh, Lee, Gary Y. C., Drudy, Enya and Francis, Roslyn J. (2023). Targeted alveo-pleural fistula endobronchial valve treatment using ventilation scintigraphy. Respirology Case Reports, 11 (5) e01146. doi: 10.1002/rcr2.1146 |
|
2023 Journal Article Considerations for imaging of malignant pleural mesothelioma: a consensus statement from the International Mesothelioma Interest GroupKatz, Sharyn I., Straus, Christopher M., Roshkovan, Leonid, Blyth, Kevin G., Frauenfelder, Thomas, Gill, Ritu R., Lalezari, Ferry, Erasmus, Jeremy, Nowak, Anna K., Gerbaudo, Victor H., Francis, Roslyn J. and Armato, Samuel G. (2023). Considerations for imaging of malignant pleural mesothelioma: a consensus statement from the International Mesothelioma Interest Group. Journal of Thoracic Oncology, 18 (3), 278-298. doi: 10.1016/j.jtho.2022.11.018 |
|
2022 Journal Article Unravelling the role of macrophages in cardiovascular inflammation through imaging: a state-of-the-art reviewParry, Reece, Majeed, Kamran, Pixley, Fiona, Hillis, Graham Scott, Francis, Roslyn Jane and Schultz, Carl Johann (2022). Unravelling the role of macrophages in cardiovascular inflammation through imaging: a state-of-the-art review. European Heart Journal Cardiovascular Imaging, 23 (12), e504-e525. doi: 10.1093/ehjci/jeac167 |
|
2022 Journal Article Fully automatic prognostic biomarker extraction from metastatic prostate lesion segmentations in whole-body [68Ga]Ga-PSMA-11 PET/CT imagesKendrick, Jake, Francis, Roslyn J., Hassan, Ghulam Mubashar, Rowshanfarzad, Pejman, Ong, Jeremy S. L. and Ebert, Martin A. (2022). Fully automatic prognostic biomarker extraction from metastatic prostate lesion segmentations in whole-body [68Ga]Ga-PSMA-11 PET/CT images. European Journal of Nuclear Medicine and Molecular Imaging, 50 (1), 67-79. doi: 10.1007/s00259-022-05927-1 |
|
2022 Journal Article The effect of vitamin-K1 and colchicine on vascular calcification activity in subjects with diabetes mellitus (ViKCoVaC): a double-blind 2x2 factorial randomized controlled trialBellinge, Jamie W., Francis, Roslyn J., Lee, Sing Ching, Vickery, Alistair, Macdonald, William, Gan, Seng Khee, Chew, Gerard T., Phillips, Michael, Lewis, Joshua R., Watts, Gerald F. and Schultz, Carl J. (2022). The effect of vitamin-K1 and colchicine on vascular calcification activity in subjects with diabetes mellitus (ViKCoVaC): a double-blind 2x2 factorial randomized controlled trial. Journal of Nuclear Cardiology, 29 (4), 1855-1866. doi: 10.1007/s12350-021-02589-8 |
|
2022 Journal Article Event‐free survival after radical prostatectomy according to PSMA PET and EAU Biochemical Recurrence Risk GroupsRoberts, Matthew J., Chatfield, Mark D., Hruby, George, Nandurkar, Rohan, Roach, Paul, Watts, Jo Anne, Cusick, Thomas, Kneebone, Andrew, Eade, Thomas, Ho, Bao, Nguyen, Andrew, Tang, Colin, McCarthy, Michael, Francis, Roslyn, Stricker, Phillip and Emmett, Louise (2022). Event‐free survival after radical prostatectomy according to PSMA PET and EAU Biochemical Recurrence Risk Groups. BJU International, 130 (S3), 32-39. doi: 10.1111/bju.15762 |
|
2022 Journal Article The importance of training, accreditation, and guidelines for the practice of theranostics: the Australian perspectiveLee, Sze Ting, Emmett, Louise M., Pattison, David A., Hofman, Michael S., Bailey, Dale L., Latter, Melissa J., Francis, Roslyn J. and Scott, Andrew M. (2022). The importance of training, accreditation, and guidelines for the practice of theranostics: the Australian perspective. Journal of Nuclear Medicine, 63 (6), 819-822. doi: 10.2967/jnumed.122.263996 |
|
2022 Conference Publication TheraP: <sup>177</sup>Lu-PSMA-617 (LuPSMA) versus cabazitaxel in metastatic castration-resistant prostate cancer (mCRPC) progressing after docetaxel-Overall survival after median follow-up of 3 years (ANZUP 1603)Hofman, Michael S., Emmett, Louise, Sandhu, Shahneen, Iravani, Amir, Joshua, Anthony M., Goh, Jeffrey C., Pattison, David A., Tan, Thean Hsiang, Kirkwood, Ian D., Francis, Roslyn J., Gedye, Craig, Rutherford, Natalie K., Zhang, Alison Yan, McJannett, Margaret Mary, Stockler, Martin R., Williams, Scott, Martin, Andrew James and Davis, Ian D. (2022). TheraP: 177Lu-PSMA-617 (LuPSMA) versus cabazitaxel in metastatic castration-resistant prostate cancer (mCRPC) progressing after docetaxel-Overall survival after median follow-up of 3 years (ANZUP 1603). Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Virtual, 3-7 June 2022. Philadelphia, PA USA: Lippincott Williams & Wilkins. |
|
2022 Journal Article Subcutaneous sarcoidosis (Darier–Roussy sarcoidosis) with extensive disease on positron emission tomography: a case report and review of the literatureYoun, Paul, Francis, Roslyn J., Preston, Henry and Lake, Fiona (2022). Subcutaneous sarcoidosis (Darier–Roussy sarcoidosis) with extensive disease on positron emission tomography: a case report and review of the literature. Respirology Case Reports, 10 (5) e0949. doi: 10.1002/rcr2.949 |
|
2022 Conference Publication A prospective, multi-centre trial of FET-PET In Glioblastoma patients - the TROG 18.06 FIG Study: results of the Nuclear Medicine and Radiation Oncology credentialing programKoh, E. S., Moore, A., Francis, R. J., Ebert, M. A., Gan, H. K., Lee, S. T., Lau, E., Rossi, A., Grose, A., Ng, S. P., Barnes, E. H., Moffat, B. A., Scott, F. E., Adda, L., Foroudi, F., Nowak, A. K., Bailey, D. L., Back, M., Lourenco, R. De Abreu and Scott, A. M. (2022). A prospective, multi-centre trial of FET-PET In Glioblastoma patients - the TROG 18.06 FIG Study: results of the Nuclear Medicine and Radiation Oncology credentialing program. HOBOKEN: WILEY. |
|
2022 Journal Article Efficacy of probucol on cognitive function in Alzheimer's disease: study protocol for a double-blind, placebo-controlled, randomised phase II trial (PIA study)Lam, Virginie, Clarnette, Roger, Francis, Roslyn, Bynevelt, Michael, Watts, Gerald, Flicker, Leon, Orr, Carolyn F, Loh, Poh, Lautenschlager, Nicola, Reid, Christopher M., Foster, Jonathan K., Dhaliwal, Satvinder S., Robinson, Suzanne, Corti, Emily, Vaccarezza, Mauro, Horgan, Ben, Takechi, Ryusuke and Mamo, John (2022). Efficacy of probucol on cognitive function in Alzheimer's disease: study protocol for a double-blind, placebo-controlled, randomised phase II trial (PIA study). BMJ Open, 12 (2) e058826, e058826. doi: 10.1136/bmjopen-2021-058826 |
|
2022 Conference Publication PSMA PET and FDG PET as predictors of response and prognosis in a randomized phase 2 trial of <SUP>177</SUP>Lu-PSMA-617 (LuPSMA) versus cabazitaxel in metastatic, castration-resistant prostate cancer (mCRPC) progressing after docetaxel (TheraP ANZUP 1603)Buteau, James Patrick, Martin, Andrew James, Emmett, Louise, Iravani, Amir, Sandhu, Shahneen Kaur, Joshua, Anthony M., Zhang, Alison Yan, Francis, Roslyn J., Scott, Andrew Mark, Azad, Arun, McJannett, Margaret Mary, Stockler, Martin R., Williams, Scott, Davis, Ian D. and Hofman, Michael S. (2022). PSMA PET and FDG PET as predictors of response and prognosis in a randomized phase 2 trial of 177Lu-PSMA-617 (LuPSMA) versus cabazitaxel in metastatic, castration-resistant prostate cancer (mCRPC) progressing after docetaxel (TheraP ANZUP 1603). ASCO Genitourinary Cancers Symposium, Electr Network, Feb 17-19, 2022. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1200/JCO.2022.40.6_suppl.010 |
|
2022 Conference Publication ENZA-p: A randomized phase II trial using PSMA as a therapeutic agent and prognostic indicator in men with metastatic castration-resistant prostate cancer treated with enzalutamide (ANZUP 1901)Emmett, Louise, Subramaniam, Shalini, Martin, Andrew James, Zhang, Alison Yan, Yip, Sonia, Crumbaker, Megan, Rana, Nisha, Francis, Roslyn J., Hofman, Michael S., Joshua, Anthony M., Sandhu, Shahneen Kaur, Azad, Arun, Gedye, Craig, Weickhardt, Andrew James, Goh, Jeffrey C., Ng, Siobhan, Voskoboynik, Mark, McJannett, Margaret Mary, Stockler, Martin R. and Davis, Ian D. (2022). ENZA-p: A randomized phase II trial using PSMA as a therapeutic agent and prognostic indicator in men with metastatic castration-resistant prostate cancer treated with enzalutamide (ANZUP 1901). ASCO Genitourinary Cancers Symposium, Electr Network, Feb 17-19, 2022. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1200/JCO.2022.40.6_suppl.TPS205 |
|
2022 Journal Article Imaging in pleural mesothelioma: a review of the 15th International Conference of the International Mesothelioma Interest GroupArmato, Samuel G., Nowak, Anna K., Francis, Roslyn J., Katz, Sharyn I., Kholmatov, Manizha, Blyth, Kevin G., Gudmundsson, Eyjolfur, Kidd, Andrew C. and Gill, Ritu R. (2022). Imaging in pleural mesothelioma: a review of the 15th International Conference of the International Mesothelioma Interest Group. Lung Cancer, 164, 76-83. doi: 10.1016/j.lungcan.2021.12.008 |
|
2022 Journal Article The effect of vitamin K1 on arterial calcification activity in subjects with diabetes mellitus: a post hoc analysis of a double-blind, randomized, placebo-controlled trialBellinge, Jamie W., Francis, Roslyn J., Lee, Sing C., Bondonno, Nicola P., Sim, Marc, Lewis, Joshua R., Watts, Gerald F. and Schultz, Carl J. (2022). The effect of vitamin K1 on arterial calcification activity in subjects with diabetes mellitus: a post hoc analysis of a double-blind, randomized, placebo-controlled trial. The American Journal of Clinical Nutrition, 115 (1), 45-52. doi: 10.1093/ajcn/nqab306 |
